Efficient production of high specific activity 64Cu using a biomedical cyclotron.
8 auth.
D. McCarthy,
R. Shefer,
R. Klinkowstein,
L. Bass,
W. Margeneau,
Cathy S. Cutler,
...
Carolyn J. Anderson,
Michael J. Welch
|
8 |
1997 |
8
1997
|
Graphical analysis of PET data applied to reversible and irreversible tracers.
J. Logan
|
8 |
1999 |
8
1999
|
Serotonin-1A receptor imaging in recurrent depression: replication and literature review.
7 auth.
W. Drevets,
M. Thase,
E. Moses-Kolko,
J. Price,
E. Frank,
D. Kupfer,
...
C. Mathis
|
8 |
2007 |
8
2007
|
Standardized methods for the production of high specific-activity zirconium-89.
J. Holland,
Y. Sheh,
Jason S. Lewis
|
8 |
2009 |
8
2009
|
FDG accumulation and tumor biology.
E. Pauwels,
M. J. Ribeiro,
J. Stoot,
V. McCready,
M. Bourguignon,
B. Maziére
|
8 |
1998 |
8
1998
|
Copper radionuclides and radiopharmaceuticals in nuclear medicine.
P. Blower,
P. Blower,
Jason S. Lewis,
J. Zweit
|
8 |
1996 |
8
1996
|
PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.
M. Deri,
Brian M. Zeglis,
L. Francesconi,
Jason S. Lewis
|
8 |
2013 |
8
2013
|
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
8 auth.
K. Langen,
K. Hamacher,
M. Weckesser,
F. Floeth,
G. Stoffels,
D. Bauer,
...
H. Coenen,
D. Pauleit
|
8 |
2006 |
8
2006
|
PET and [18F]-FDG in oncology: a clinical update.
P. Conti,
D. Lilien,
K. Hawley,
J. Keppler,
Scott T. Grafton,
J. Bading
|
8 |
1996 |
8
1996
|
In vivo biodistribution and accumulation of 89Zr in mice.
D. Abou,
Thomas Ku,
P. Smith-Jones
|
7 |
2011 |
7
2011
|
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells.
9 auth.
Mitsuyoshi Yoshimoto,
A. Waki,
Yoshiharu Yonekura,
Norihiro Sadato,
T. Murata,
N. Omata,
...
Norio Takahashi,
Michel J. Welch,
Y. Fujibayashi
|
7 |
2001 |
7
2001
|
F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
Wei Zhang,
S. Oya,
M. Kung,
C. Hou,
D. Maier,
H. Kung
|
7 |
2005 |
7
2005
|
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
10 auth.
D. Sorger,
M. Patt,
Piyush Kumar,
L. Wiebe,
H. Barthel,
A. Seese,
...
C. Dannenberg,
A. Tannapfel,
R. Kluge,
O. Sabri
|
7 |
2003 |
7
2003
|
Assays for noninvasive imaging of reporter gene expression.
S. Gambhir,
J. Barrio,
H. Herschman,
M. Phelps
|
7 |
1999 |
7
1999
|
Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
J. Mukherjee,
Zhi-Ying Yang,
M. Das,
Terry A Brown
|
7 |
1995 |
7
1995
|
Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.
C. Boswell,
M. Brechbiel
|
7 |
2007 |
7
2007
|
